Cui E - Search Results

1

Successful administration of low-dose almonertinib in a patient with lung adenocarcinoma after osimertinib-induced interstitial lung disease: a case report and literature review.

Chen W, Zhang L, Shen H, Wang B, Luo J, Cui E. Chen W, et al. Among authors: cui e. Anticancer Drugs. 2023 Mar 1;34(3):460-466. doi: 10.1097/CAD.0000000000001436. Epub 2022 Nov 14. Anticancer Drugs. 2023. PMID: 36373747 Free PMC article. Review.

2

The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.

Cui E, Deng A, Wang X, Wang B, Mao W, Feng X, Hua F. Cui E, et al. Biochem Cell Biol. 2011 Jun;89(3):308-13. doi: 10.1139/o11-005. Epub 2011 May 27. Biochem Cell Biol. 2011. PMID: 21619462

3

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.

Cui EH, Li HJ, Hua F, Wang B, Mao W, Feng XR, Li JY, Wang X. Cui EH, et al. Acta Pharmacol Sin. 2013 Feb;34(2):309-13. doi: 10.1038/aps.2012.125. Epub 2012 Sep 17. Acta Pharmacol Sin. 2013. PMID: 22983388 Free PMC article.

4

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

Wang X, Cui E, Zeng H, Hua F, Wang B, Mao W, Feng X. Wang X, et al. Among authors: cui e. PLoS One. 2012;7(10):e43734. doi: 10.1371/journal.pone.0043734. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071492 Free PMC article.

5

Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.

Ma Z, Li H, Wang B, Shen Q, Cui E, Min L, Qian F, Ping J, Dai L. Ma Z, et al. Among authors: cui e. J Cancer Res Clin Oncol. 2013 Apr;139(4):557-62. doi: 10.1007/s00432-012-1357-1. Epub 2012 Dec 7. J Cancer Res Clin Oncol. 2013. PMID: 23224432

6

RNA-Sequencing approach for exploring the therapeutic effect of umbilical cord mesenchymal stem/stromal cells on lipopolysaccharide-induced acute lung injury.

Cui E, Zhang L, Pan X, Zhang Q, Zhang L, Wu F, Chen N, Lv L, Chen W, Chen H, Lin A, Wang F, Liang J, Pan R. Cui E, et al. Front Immunol. 2022 Oct 20;13:1021102. doi: 10.3389/fimmu.2022.1021102. eCollection 2022. Front Immunol. 2022. PMID: 36341363 Free PMC article.

7

Mesenchymal stem/stromal cell-based cell-free therapy for the treatment of acute lung injury.

Cui E, Lv L, Chen W, Chen N, Pan R. Cui E, et al. J Cell Biochem. 2023 Sep;124(9):1241-1248. doi: 10.1002/jcb.30469. Epub 2023 Sep 5. J Cell Biochem. 2023. PMID: 37668145 Review.

8

Fecal microbiota transplantation from HUC-MSC-treated mice alleviates acute lung injury in mice through anti-inflammation and gut microbiota modulation.

Hua F, Cui E, Lv L, Wang B, Li L, Lu H, Chen N, Chen W. Hua F, et al. Among authors: cui e. Front Microbiol. 2023 Sep 28;14:1243102. doi: 10.3389/fmicb.2023.1243102. eCollection 2023. Front Microbiol. 2023. PMID: 37840733 Free PMC article.

9

Multiomics reveal human umbilical cord mesenchymal stem cells improving acute lung injury via the lung-gut axis.

Lv L, Cui EH, Wang B, Li LQ, Hua F, Lu HD, Chen N, Chen WY. Lv L, et al. World J Stem Cells. 2023 Sep 26;15(9):908-930. doi: 10.4252/wjsc.v15.i9.908. World J Stem Cells. 2023. PMID: 37900940 Free PMC article.

10

Umbilical cord MSC-derived exosomes improve alveolar macrophage function and reduce LPS-induced acute lung injury.

Cui E, Lv L, Wang B, Li L, Lu H, Hua F, Chen W, Chen N, Yang L, Pan R. Cui E, et al. J Cell Biochem. 2024 Feb;125(2):e30519. doi: 10.1002/jcb.30519. Epub 2024 Jan 15. J Cell Biochem. 2024. PMID: 38224137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters